Syndax Pharmaceuticals (SNDX) Short Interest Ratio & Short Volume → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free SNDX Stock Alerts $20.96 +0.16 (+0.77%) (As of 04/22/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Syndax Pharmaceuticals Short Interest DataCurrent Short Volume9,620,000 sharesPrevious Short Volume8,330,000 sharesChange Vs. Previous Month+15.49%Dollar Volume Sold Short$228.96 millionShort Interest Ratio / Days to Cover8.2Last Record DateMarch 31, 2024Outstanding Shares84,960,000 sharesPercentage of Shares Shorted11.32%Today's Trading Volume665,026 sharesAverage Trading Volume938,424 sharesToday's Volume Vs. Average71% Short Selling Syndax Pharmaceuticals ? Sign up to receive the latest short interest report for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSNDX Short Interest Over TimeSNDX Days to Cover Over TimeSNDX Percentage of Float Shorted Over Time Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Syndax Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20249,620,000 shares $228.96 million +15.5%N/A8.2 $23.80 3/15/20248,330,000 shares $195.92 million -8.4%N/A6.9 $23.52 2/29/20249,090,000 shares $213.07 million +5.7%N/A6.1 $23.44 2/15/20248,600,000 shares $194.96 million -1.0%N/A5.8 $22.67 1/31/20248,690,000 shares $178.06 million No ChangeN/A5.8 $20.49 1/15/20248,690,000 shares $193.27 million +3.7%N/A5.4 $22.24 Get the Latest News and Ratings for SNDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20238,380,000 shares $181.09 million -19.0%N/A4.7 $21.61 12/15/202310,340,000 shares $214.76 million +1.1%N/A4.8 $20.77 11/30/202310,230,000 shares $170.28 million -3.7%N/A5.4 $16.65 11/15/202310,620,000 shares $159.94 million +6.4%N/A6.2 $15.06 10/31/20239,980,000 shares $140.52 million +17.4%N/A6.1 $14.08 10/15/20238,500,000 shares $101.92 million +12.1%N/A5.7 $11.99 9/30/20237,580,000 shares $110.06 million -0.1%N/A6 $14.52 9/15/20237,590,000 shares $131.76 million +9.1%N/A9.8 $17.36 8/31/20236,960,000 shares $128.83 million -2.8%N/A8.8 $18.51 8/15/20237,160,000 shares $132.03 million +7.7%N/A8.4 $18.44 7/31/20236,650,000 shares $141.78 million +12.1%N/A7.4 $21.32 7/15/20235,930,000 shares $125.42 million +3.3%N/A6.8 $21.15 6/30/20235,740,000 shares $120.14 million +2.5%N/A6.5 $20.93 6/15/20235,600,000 shares $119.45 million -10.0%N/A5.9 $21.33 5/31/20236,220,000 shares $124.21 million -2.7%N/A6.7 $19.97 5/15/20236,390,000 shares $135.15 million -2.0%N/A7.4 $21.15 4/30/20236,520,000 shares $133.99 million -5.2%N/A7.9 $20.55 4/15/20236,880,000 shares $137.60 million -9.8%N/A8.6 $20.00 3/31/20237,630,000 shares $161.15 million +12.4%N/A9.5 $21.12 3/15/20236,790,000 shares $151.42 million +13.4%N/A8.9 $22.30 2/28/20235,990,000 shares $151.85 million +8.5%N/A7 $25.35 2/15/20235,520,000 shares $143.46 million +0.6%N/A6.8 $25.99 1/31/20235,490,000 shares $157.56 million +0.6%N/A6.5 $28.70 1/15/20235,460,000 shares $143.65 million -14.3%N/A6.4 $26.31 12/30/20226,370,000 shares $162.12 million +22.5%N/A7.3 $25.45 12/15/20225,200,000 shares $125.84 million +17.7%N/A6.1 $24.20 11/30/20224,420,000 shares $105.90 million +5.7%N/A5.8 $23.96 11/15/20224,180,000 shares $91.46 million +2.7%N/A6 $21.88 10/31/20224,070,000 shares $93.45 million -9.2%N/A5.9 $22.96 10/15/20224,480,000 shares $105.41 million +0.9%9.4%6.7 $23.53 9/30/20224,440,000 shares $106.69 million -3.5%9.3%6.7 $24.03 9/15/20224,600,000 shares $113.02 million No Change9.6%7.2 $24.57 8/31/20224,600,000 shares $108.61 million +0.4%9.7%7 $23.61 8/15/20224,580,000 shares $113.31 million +5.1%9.6%7.1 $24.74Incredible Opportunity to Retire FAST! (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide SNDX Short Interest - Frequently Asked Questions What is Syndax Pharmaceuticals' current short interest? Short interest is the volume of Syndax Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 9,620,000 shares of SNDX short. Learn More on Syndax Pharmaceuticals' current short interest. What is a good short interest ratio for Syndax Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNDX shares currently have a short interest ratio of 8.0. Learn More on Syndax Pharmaceuticals's short interest ratio. Which institutional investors are shorting Syndax Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Syndax Pharmaceuticals: Frazier Life Sciences Management L.P., Worth Venture Partners LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Syndax Pharmaceuticals' short interest increasing or decreasing? Syndax Pharmaceuticals saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 9,620,000 shares, an increase of 15.5% from the previous total of 8,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Syndax Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Syndax Pharmaceuticals: Schrödinger, Inc. (8.63%), Catalyst Pharmaceuticals, Inc. (6.06%), Structure Therapeutics Inc. (9.03%), NewAmsterdam Pharma (0.86%), Avidity Biosciences, Inc. (12.52%), Harmony Biosciences Holdings, Inc. (20.65%), PTC Therapeutics, Inc. (13.39%), Amneal Pharmaceuticals, Inc. (2.17%), Galapagos NV (2.18%), Geron Co. (8.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Syndax Pharmaceuticals stock? Short selling SNDX is an investing strategy that aims to generate trading profit from Syndax Pharmaceuticals as its price is falling. SNDX shares are trading up $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Syndax Pharmaceuticals? A short squeeze for Syndax Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNDX, which in turn drives the price of the stock up even further. How often is Syndax Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNDX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: SDGR Short Squeeze CPRX Short Squeeze GPCR Short Squeeze NAMS Short Squeeze RNA Short Squeeze HRMY Short Squeeze PTCT Short Squeeze AMRX Short Squeeze GLPG Short Squeeze GERN Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNDX) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe #1 Crypto for 2024InvestorPlace